  See all
 |
Articles: Colorectal Cancer/Polyps |
Prior Articles
Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial
Clinical Cancer Research, 09/08/09
Tumor Cell-Microenvironment Interaction Models Coupled with Clinical Validation Reveal CCL2 and SNCG as Two Predictors of Colorectal Cancer Hepatic Metastasis
Clinical Cancer Research, 09/08/09 Differences in Repair of DNA Cross-links between Lymphocytes and Epithelial Tumor Cells from Colon Cancer Patients Measured In vitro with the Comet Assay
Clinical Cancer Research, 09/08/09 KRAS mutational status assessment in patients with metastatic colorectal cancer: are the clinical implications so clear
European Journal of Cancer Care, 09/08/09 Mapping the information resources available to patients with colorectal cancer
European Journal of Cancer Care, 09/08/09 Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK
European Journal of Cancer Care, 09/08/09 Cancer stem cell marker CD133+ tumour cells and clinical outcome in rectal cancer
Histopathology, 09/04/09 Factors triggering medical consultation for symptoms of colorectal cancer and perceptions surrounding diagnosis
European Journal of Cancer Care, 09/04/09 15d-PGJ2 Induces Apoptosis by Reactive Oxygen Species–mediated Inactivation of Akt in Leukemia and Colorectal Cancer Cells and Shows In vivo Antitumor Activity
Clinical Cancer Research, 09/04/09 Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members
Journal of Clinical Oncology, 09/03/09 Effect of folic acid supplementation on the progression of colorectal aberrant crypt foci
Carcinogenesis, 09/03/09 (–)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells
Carcinogenesis, 09/03/09 Over-expression of EphB3 enhances cell–cell contacts and suppresses tumor growth in HT-29 human colon cancer cells
Carcinogenesis, 09/03/09 Expression of FXYD-3 is an Independent Prognostic Factor in Rectal Cancer Patients With Preoperative Radiotherapy
International Journal of Radiation Oncology*Biology*Physics, 09/02/09 Racial Differences in Advanced Colorectal Cancer Outcomes and Pharmacogenetics: A Subgroup Analysis of a Large Randomized Clinical Trial
Journal of Clinical Oncology, 09/02/09 Cumulative Risk of Colon Cancer up to Age 70 Years by Risk Factor Status Using Data From the Nurses’ Health Study
American Journal of Epidemiology, 09/02/09 Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
Journal of Clinical Oncology, 09/02/09 Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomized phase II study
Annals of Oncology, 09/01/09 Treatment of Fluorouracil-Refractory Patients With Liver Metastases From Colorectal Cancer by Using Yttrium-90 Resin Microspheres Plus Concomitant Systemic Irinotecan Chemotherapy
Journal of Clinical Oncology, 09/01/09 Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus
Human Pathology, 09/01/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
